Immune Therapeutics names new president, COO
This article was originally published in Scrip
Immune Therapeutics, a specialty pharmaceutical company developing therapies based on the activation and modulation of the body's immune system, has named Seth Elliott president and chief operating officer. Mr Elliott has spent more than 15 years as a founder or senior executive of emerging growth and middle market enterprises. His previous roles include: chief strategy officer of Engagement Media Technologies; vice-president, business development for FastCall; and founder of Pegasus Advisory group.